Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-01-06

Clinical Trial Update: Effect of Gabapentin on Idiopathic Subjective Tinnitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating gabapentin for idiopathic subjective tinnitus. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Islamic Azad University of Mashhad | Conditions: Subjective Tinnitus | Phase 2 | Status: UNKNOWN